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Abstract The presence of receptors for oligodeoxynucleotides 
(OdN) on the surface of L929 cells has previously been described. 
To study the possible coupling of the receptor to cellular signal 
transducing systems, the effect of phosphodiester OdN of 
different sequences on cellular phospholipase C and protein 
kinase C (PKC) activities in L929 fibroblasts was studied. 
Treatment of cells with OdN induced an increase in 32p labeling 
of phosphatidic acid which was accompanied by a gradual 
decrease in diacylglycerol. These effects seem to be independent 
of the OdN sequence. PKC activity in membranes isolated from 
OdN-treated cells was found to be lower than that in membranes 
of control cells. SDS-PAGE of the 32P-Iabeled cellular proteins 
revealed that OdN treatment caused a decrease in phosphoryla-
tion of the 26 and 73 kDa cellular proteins in the cells. 
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1. Introduction 
The existence of cell surface receptors for extracellular oli-
gonucleotides has previously been demonstrated (reviewed in 
[I]). It is well known that extracellular nucleotides and nucleo-
sides have their own receptors on the cell surface and through 
such receptors can influence many biological processes. The 
biological effects of nucleotides and nucleosides on cells are 
mediated by signal-transducing systems, in particular that of 
phospholipase C. For example, the addition of ATP to cells 
results in receptor-coupled activation of phosphatidylinositol-
specific phospholipase C and elevation of intracellular free 
Ca2+ ([Ca2+]i) [2,3]. Other nucleotides, such as GTP and 
UTP, can also elicit cellular response by stimulation of phos-
phoinositide hydrolysis and elevation of [Ca2+]i [4,5]. A re-
cently described third type of A-receptors, sensitive to adeno-
sine and AMP, was found to be coupled to the phospholipase 
C signaling system [6]. 
The aim of this study was to examine the possible coupling 
of the OdN receptor to the phospholipase C (PLC)-protein 
kinase C (PKC) signal-transducing pathway. The investiga-
tion was performed with the murine fibroblast L929 cell 
line, which was selected for experiments as these cells have 
been shown to contain a surface 79 kDa oligonucleotide-bind-
ing protein (putative receptor) and the protein is present in 
greater amounts as compared with other cell lines tested [7,8]. 
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Abbreviations: DAG, diacylglycerol; d(pNI6), pTCACCCTCTTCC-
CA TC; d(pN'16), pAT ACCCTGCTTTTGCT; depT 10), 
pTTTTTTTTTT; OdN, oligodeoxynucleotide(s); PKC, protein kinase 
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2. Materials and methods 
2.1. Materials 
32Pi (5000 Ci/mmol), [y_32p]ATP, was from 'Biosan' (Novosibirsk, 
Russia) and sodium [14C]acetate (50 mCi/mmol) from 'Isotope' (St. 
Petersburg, Russia). The oligodeoxynucleotides d(pN16) [pTCACC-
CTCTTCCCATC] and d(pN'16) [pATACCCTGCTTTTGCT] com-
plementary to vernal encephalitis virus and influenza virus mRNA, 
respectively, and depT 10), were synthesized using the triester method 
in solution in the Novosibirsk Institute of Bioorganic Chemistry as 
described in [9], purified by reverse-phase HPLC, precipitated with 
lithium perchlorate in acetone, washed with acetone and kept dry. 
Dulbecco's modified Eagle's medium (DMEM), fetal calf serum 
(FCS) and Hank's solution were from 'Vector' (Novosibirsk, Russia). 
Phosphatidic acid and 1,2-dioleoyl-sn-glycerol used as standards were 
from Sigma (St. Louis, USA). 
2.2. Cell culture 
L929 murine fibroblasts were grown in DMEM supplemented with 
6% FCS, 2 mM glutamine and 40 ~g/ml gentamycin in a humidified 
atmosphere of 5% CO2. 2 days after plating, the medium was replaced 
with serum-free medium. Cells which had rested in serum-free medium 
for 1-2 days were used as quiescent cells. Cells were treated with 
oligonucleotides in serum-free medium. 
2.3. Labeling of cellular lipids with t 4 Cjacetate (or 32Pi) and lipid 
analysis 
During the serum deprivation period, confluent L929 cells were 
incubated with sodium [14C]acetate (250 ~Ci/ml). 32Pi was added to 
cells (80 ~Ci/ml) simultaneously with OdN or as described in the text. 
Cellular monolayers were extracted as described [10]. Lipids were ex-
tracted according to Bligh and Dyer [II]. Extracted lipids were ana-
lyzed by TLC on silica gel 60 coated plates (0.2 mm, E. Merck, 
Darmstadt, Germany). To separate neutral lipids from phospholipids, 
samples were first developed to the middle of the plate in diethyl 
ether. After removing the top half of the plate containing neutral 
lipids, the plates were finally developed in solvent comprising chloro-
formlmethanollacetone/acetic acid/H20 (10:2:4:2: I, v/v) to separate 
phospholipids. Neutral lipids were separated using a solvent consist-
ing of hexane/diethyl ether/acetic acid (60:40:1, v/v). Lipid spots were 
detected by autoradiography, identified by comparison with known 
standards and scraped off. Radioactivity of lipids was measured by 
liquid scintillation or autoradiograms were scanned with an Ultrascan 
XL laser densitometer (LKB). 
2.4. SDS-PAGE 
Cells preincubated in the presence of oligonucleotides and 32Pi (100 
~Ci/ml) were boiled with Laemmli sample buffer for 5 min and elec-
trophoresis was performed on 12% acrylamide gels [12]. Dried gels 
were submitted to autoradiography. 
2.5. Membrane-associated protein kinase C activity 
Cellular membrane fractions were obtained as described [13]. Pro-
tein concentration was determined according to Bradford, PKC activ-
ity in membranes being assayed by measuring the phosphorylation of 
histone HI and determined as the difference in the amount of incor-
porated 32p radioactivity in the presence and absence of activators 
(Ca2+ and phosphatidylserine) [14]. 
3. Results 
Accumulation of radiolabeled phosphatidic acid (PtdOH) in 
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Fig. I. Sequence-independent effect of OdN on 32p turnover of 
PtdOH. (A) L929 cells were incubated in the presence of I )lM 
d(pTlO) (lanes 3,4; replicates) and 32Pi (80 )lCi/ml) for 2 h or in the 
absence of OdN (lanes 1,2; replicates). Lipids were extracted and 
separated by TLC as described in Section 2. (B) Time course of 32p 
labeling of cellular phospholipids in the presence or absence of 
d(pN16) (I )lM). 32Pi was added to cells as described in (A). (C) 
The same as in (B) except that d(pN16) were added to fibroblasts 
prelabeled with 32Pi for 30 min. PtdCho, phosphatidylcholine; 
PtdOH, phosphatidic acid; PtdEt, phosphatidylethanolamine. 
cells stimulated with agonists in the presence of 32pj is con-
sidered as an indication that agonists cause DAG liberation in 
cells due to phospholipase C (PLC) activation [15]. To assess 
whether oligonucleotides could activate PLC, we first exam-
ined 32p incorporation into phospholipids of L929 cells. Dec-
athymidylate (d(pTlO)) was added to cells simultaneously with 
32p j to 10-6 M final concentration. Fig. I shows that addition 
of OdN to quiescent cells had no effect on phosphatidylcho-
line (PtdCho) and phosphatidylethanolamine labeling (PtdEt). 
In contrast, significant induction of PtdOH radio labeling was 
found in OdN-treated cells. Addition of another OdN, 
d(pNI6), gave similar results, a near 2-fold increase in PtdOH 
radiolabeling after 90 min incubation being observed (data 
not shown). 
A characteristic feature of receptor-stimulated activation of 
phospholipase C is the rapidity of the process, leading to the 
formation of DAG within the first 30 s after ligand addition 
[16]. In contrast, penetration of the compound by endocytosis 
is rather slow process. To determine whether increased radio-
labeling of PtdOH is the result of OdN interaction with the 
cell surface or its penetration into cells, the time course of 
OdN-induced changes in phospholipid radiolabeling was stud-
ied. Fig. IC shows that stimulated PtdOH turnover was ob-
served as fast as 40 s after OdN addition. 
These results prompted us to investigate whether the rise in 
PtdOH radiolabeling was due to increased DAG production. 
Fig. 2 illustrates that addition of d(pNI6) causes a gradual 
decrease in the [14C]DAG level in cells. Similarly, treatment 
of quiescent L929 cells with an OdN having a different se-
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quence d(pN'16) (5 X 1O-7M) for 90 min results in an '" 25% 
decrease in [14C]DAG (9980 ± 2300 and 7600 ± 1700 cpml1 05 
cells before and after OdN addition, respectively). 
The next series of experiments were performed in order to 
examine the relationship between 32p radio labeling of PtdOH, 
[14C]DAG level and concentration of added OdN. Quiescent 
fibroblasts were first prelabeled with e4C]acetate and then 
treated with various concentrations of d(pNI6) in the presence 
of 32pj. It was found that, in cells, OdN resulted in a dose-
dependent increase in [32 pJPtdOH radiolabeling ('" 200% 
maximal effect) and a slight decrease in [14C]DAG level 
( '" 20%) (Fig. 2B). Despite the fact that the decrease in 
DAG was found to be slight, it was reproducible. 
When the effect of OdN on cellular protein phosphorylation 
was studied, it was found that the pattern of cellular protein 
phosphorylation was altered in OdN-treated cells. Fig. 3A 
illustrates the effect of OdN on 32p incorporation into cellular 
proteins. It was observed that radiolabeling of some cellular 
proteins, namely, those of 26 and 73 kDa, was reduced in 
OdN-treated fibroblasts (lanes 3,4) compared to control (lanes 
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Fig. 2. Effect of OdN on cellular [14C]DAG. (A) Changes in the 
amount of [14C]DAG in L929 fibroblasts following OdN treatment. 
Cells were labeled for 24 h with [14C]acetate and then treated with 
d(pN 16) (I )lM) for various times. (B) Effect of different concentra-
tions of OdN on changes in [14C]DAG level and [32 pJPtdOH label-
ing. Cells prelabeled with [14C]acetate were treated with different 
concentrations of d(pN16) for 2 h. 32Pi (100 )lCi/ml) was added to 
cells simultaneously with OdN. Lipids were extracted, separated by 
TLC and 14C radioactivity of DAG (e) and 32p radioactivity of 
PtdOH (_) were measured. 
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Fig. 3. Effect of OdN on cellular protein kinase activity. (A) 32p incorporation into cellular proteins. L929 fibroblasts (1.1 X 105 cells) were pre-
incubated for 90 min with p(N 16) (111M) (lanes 3,4) or in its absence (lanes 1,2). The cells were then incubated with 32pj (100 IlCi/ml) for a 
further 30 min and cellular proteins were then submitted to 12% SDS-PAGE. (B) Fibroblasts (1.1 X 105 cells) were incubated in the presence of 
d(pTIO) (111M) for 30 min, homogenized and membrane fractions were obtained. PKC activity in membranes of control (a) and oligonucleo-
tide-treated (b) cells was assayed by measuring phosphorylation of histone HI and determined as the difference in the amount of 32p incorpo-
rated into histone HI (400 Ilg/ml) in the presence of activators (e-e): 0.5 mM Ca2+ and 20 Ilg/ml phosphatidylserine and in their absence 
(0-0). 
1,2). This finding could reflect the inhibition of some cellular 
protein kinase(s) in cells treated with OdN. 
Previously, it was found that the addition of OdN to cells 
inhibited cellular protein-kinase C-dependent processes in a 
sequence-independent manner [17]. Activation of PKC results 
from at least three processes: translocation of the enzyme 
from the cytosol to membranes, formation of the complexes 
with phosphatidylserine in the membranes and activation of 
the complex by DAG [18]. Since the DAG level was found to 
decrease in OdN-treated cells, a lower level of PKC activity 
could be expected in membranes of these cells. PKC activity 
in membranes of control and oligonucleotide-treated L929 
cells was assayed by measuring Ca2+ -, phosphatidylserine-de-
pendent phosphorylation of histone HI and indeed, the ad-
ministration of OdN to cells induced a decrease in membrane-
associated protein kinase C activity (Fig. 3A). 
4. Discussion 
The results of our study demonstrate that (l) 32p turnover 
of PtdOH is stimulated in oligonucleotide-treated L929 cells. 
The rate of change induced in lipid metabolism suggests the 
possible participation of an OdN receptor. (2) The DAG level 
is decreased. (3) Protein kinase C activity in membranes of 
OdN-treated cells is diminished as well as the degree of phos-
phorylation of some cellular proteins. (4) The observed oligo-
nucleotide effects are sequence-independent. 
32p turnover of phosphatidylinositol and its derivatives 
(Ptdlns, PtdInsP and PtdInsP2) as well as phosphatidic acid 
is stimulated when cells are incubated with ligands specific for 
a cellular receptor, providing that the receptor is coupled to 
the phospholipase C signal-transducing system [15]. The turn-
over of inositol lipids is increased due to stimulated hydrolysis 
of one of them, PtdInsP2 , by PLC, whereas an increase in 
PtdOH radiolabeling is the result of DAG formation and its 
subsequent phosphorylation by DAG kinase, one of the en-
zymes which regulate cellular level of DAG [16]. In our ex-
periments, in cells, the addition of oligonucleotides to L929 
fibroblasts causes rapid, increased 32p incorporation into 
PtdOH (Figs. I and 2), suggesting the possible activation of 
phospholipase C by oligonucleotides and DAG liberation. 
However, measurements of the amount of DAG in 
[14C]acetate-prelabeled cells have shown that the addition of 
OdN did not induce DAG production. On the contrary, the 
DAG level was reduced in OdN-treated cells (Fig. 2A). The 
reason for this is not well understood. 
Addition of OdN to cells was found to result in a lower 
degree of phosphorylation of cellular 26 and 73 kDa proteins 
(Fig. 3A) and a loss of PKC activity in cellular membranes 
(Fig. 3B). Thus, it appears likely that the effect of OdN on 
phosphorylation of cellular proteins can be explained by the 
inhibition of cellular protein kinase C, possibly, via the de-
crease in cellular DAG level. 
Our study describes sequence-independent effects of oligo-
deoxynucleotides on cellular lipids and PKC. Protein kinase C 
is known to regulate the expression of certain oncogenes. In 
view of our results, it seems plausible to consider that expres-
sion of PKC-regulated oncogenes can be inhibited by OdN 
treatment in a sequence-independent manner. Some additional 
sequence-independent effects of OdN are known [19]. For ex-
ample, treatment of cells with phosphothioate analogs of oli-
gonucleotides and to a lesser extent with phospho diester oli-
gonucleotides resulted in sequence-independent inhibition of 
endocytosis, a PKC-dependent process in HL60 cells [17]. 
Moreover, it has been reported that OdN added to cells can 
induce Spl transcription factor, also in a sequence-independ-
ent manner [20]. A number of oligonucleotide-protein inter-
actions capable of affecting different cellular processes have 
270 
been detected recently [21]. In addition, in view of the use of 
antisense oligodeoxynucleotides to inhibit specifically gene ex-
pression, the question of understanding OdN action may be of 
importance. 
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